Insider Trading & Ownership - Leggett Thomas

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Leggett Thomas
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-01-08
Sale
2021-01-11
5:59 pm
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$33.94$101,820218,171
(Direct)
View
2020-12-08
Sale
2020-12-10
4:16 pm
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$33.78$101,327221,171
(Direct)
View
2020-11-09
Sale
2020-11-12
5:00 pm
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$32.96$98,892224,171
(Direct)
View
2020-10-08
Sale
2020-10-09
4:12 pm
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$33.53$100,576227,171
(Direct)
View
2020-09-14
Sale
2020-09-16
6:09 pm
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$31$93,000230,171
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-15
Option Award
2024-05-17
4:14 pm
N/A
2034-05-14
Stoke Therapeutics Inc.STOKLeggett Thomas
Chief Financial Officer
396,200$0396,200
(Direct)
View

Ownership
2021-03-17
9:45 pm
N/A
N/A
Research Alliance Corp. IIRACBLeggett Thomas
Director
0$030,000
(Direct)
View
2021-02-17
Option Award
2021-02-19
6:47 pm
N/A
2031-02-16
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
75,000$075,000
(Direct)
View
2021-01-08
Exercise
2021-01-11
5:59 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$0218,171
(Direct)
View
2021-01-08
Exercise
2021-01-11
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$10.86218,171
(Direct)
View
2020-12-08
Exercise
2020-12-10
4:16 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$0221,171
(Direct)
View
2020-12-08
Exercise
2020-12-10
4:16 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$10.86221,171
(Direct)
View
2020-11-09
Exercise
2020-11-12
5:00 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$0224,171
(Direct)
View
2020-11-09
Exercise
2020-11-12
5:00 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$10.86224,171
(Direct)
View
2020-10-08
Exercise
2020-10-09
4:12 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$0227,171
(Direct)
View
2020-10-08
Exercise
2020-10-09
4:12 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$10.86227,171
(Direct)
View
2020-09-14
Exercise
2020-09-16
6:09 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$0230,171
(Direct)
View
2020-09-14
Exercise
2020-09-16
6:09 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
3,000$10.86230,171
(Direct)
View
2020-01-29
Option Award
2020-01-31
4:55 pm
N/A
2030-01-29
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
55,540$055,540
(Direct)
View

Ownership
2020-01-29
8:03 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc.BDTXLeggett Thomas
Chief Financial Officer
0$0288,711
(Direct)
View